ST elevation myocardial infarction coronary artery bypass grafting: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{Infobox_Disease |
{{ST elevation myocardial infarction}}
  Name          = Myocardial infarction|
{{CMG}}; '''Associate Editors-In-Chief:''' {{CZ}}
  Image          = AMI scheme.png |
  Caption        = Diagram of a '''myocardial infarction''' (2) of the tip of the [[Sternocostal surface|anterior wall of the heart]] (an ''apical infarct'') after occlusion (1) of a branch of the [[left coronary artery]] (LCA, [[right coronary artery]] = RCA).|
  DiseasesDB    = 8664 |
  ICD10          = {{ICD10|I|21||i|20}}-{{ICD10|I|22||i|20}} |
  ICD9          = {{ICD9|410}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = 000195 |
  eMedicineSubj  = med |
  eMedicineTopic = 1567 |
  eMedicine_mult = {{eMedicine2|emerg|327}} {{eMedicine2|ped|2520}} |
  MeshID        = |
}}


'''For patient information click [[Heart attack (patient information)|here]]'''
==Overview==
 
{{CMG}}
__NOTOC__
'''Associate Editors-In-Chief:''' {{CZ}}
{{WikiDoc Cardiology Network Infobox}}
{{Editor Join}}
 
==Coronary Artery Bypass Surgery==
{{Main|Coronary artery bypass graft surgery}}
[[Image:Coronary artery bypass surgery Image 657B-PH.jpg|thumb|left|200px|'''Coronary artery bypass surgery''' during mobilization (freeing) of the [[right coronary artery]] from its surrounding tissue, [[adipose tissue]] (yellow).  The tube visible at the bottom is the aortic cannula (returns blood from the [[Heart-lung machine|HLM]]).  The tube above it (obscured by the [[cardiac surgeon|surgeon]] on the right) is the venous cannula (receives blood from the body).  The patient's [[heart]] is stopped and the [[aorta]] is cross-clamped.  The patient's head (not seen) is at the bottom.]]
[[Image:Coronary artery bypass surgery Image 657B-PH.jpg|thumb|left|200px|'''Coronary artery bypass surgery''' during mobilization (freeing) of the [[right coronary artery]] from its surrounding tissue, [[adipose tissue]] (yellow).  The tube visible at the bottom is the aortic cannula (returns blood from the [[Heart-lung machine|HLM]]).  The tube above it (obscured by the [[cardiac surgeon|surgeon]] on the right) is the venous cannula (receives blood from the body).  The patient's [[heart]] is stopped and the [[aorta]] is cross-clamped.  The patient's head (not seen) is at the bottom.]]


Despite the guidelines, emergency bypass surgery for the treatment of an acute myocardial infarction (MI) is less common then PCI or medical management. In an analysis of patients in the U.S. National Registry of Myocardial Infarction (NRMI) from January 1995 to May 2004, the percentage of patients with [[cardiogenic shock]] treated with primary PCI rose from 27.4% to 54.4%, while the increase in CABG treatment was only from 2.1% to 3.2%.<ref name="pmid16046651">{{cite journal |author=Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS |title=Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock |journal=JAMA |volume=294 |issue=4 |pages=448–54 |year=2005 |month=July |pmid=16046651 |doi=10.1001/jama.294.4.448 |url=}}</ref>
Despite the guidelines, emergency [[coronary artery bypass surgery|bypass surgery]] for the treatment of an acute myocardial infarction (MI) is less common then PCI or medical management. In an analysis of patients in the U.S. National Registry of Myocardial Infarction (NRMI) from January 1995 to May 2004, the percentage of patients with [[cardiogenic shock]] treated with primary PCI rose from 27.4% to 54.4%, while the increase in CABG treatment was only from 2.1% to 3.2%.<ref name="pmid16046651">{{cite journal |author=Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS |title=Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock |journal=JAMA |volume=294 |issue=4 |pages=448–54 |year=2005 |month=July |pmid=16046651 |doi=10.1001/jama.294.4.448 |url=}}</ref>


Emergency coronary artery bypass graft surgery (CABG) is usually undertaken to simultaneously treat a mechanical complication, such as a ruptured papillary muscle, or a ventricular septal defect, with ensueing cardiogenic shock.<ref name=Sabiston>{{cite book | last =Townsend | first =Courtney M. | coauthors =Beauchamp D.R., Evers M.B., Mattox K.L. | title =Sabiston Textbook of Surgery - The Biological Basis of Modern Surgical Practice | publisher =Elsevier Saunders | date =2004 | location =Philadelphia, Pennsylvania | pages =1871 | url =http://www.elsevier.com/wps/find/bookdescription.cws_home/701163/description#description | id =ISBN 0-7216-0409-9}}</ref> In uncomplicated MI, the [[mortality rate]] can be high when the surgery is performed immediately following the infarction.<ref name="pmid7733715">{{cite journal |author=Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR |title=Coronary artery bypass grafting within 30 days of an acute myocardial infarction |journal=Ann. Thorac. Surg. |volume=59 |issue=5 |pages=1169–76 |year=1995 |month=May |pmid=7733715 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/0003497595001255}}</ref> If this option is entertained, the patient should be stabilized prior to surgery, with supportive interventions such as the use of an [[intra-aortic balloon pump]].<ref name="pmid7598589">{{cite journal |author=Creswell LL, Moulton MJ, Cox JL, Rosenbloom M |title=Revascularization after acute myocardial infarction |journal=Ann. Thorac. Surg. |volume=60 |issue=1 |pages=19–26 |year=1995 |month=July |pmid=7598589 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/000349759500351K}}</ref> In patients developing cardiogenic shock after a myocardial infarction, both PCI and CABG are satisfactory treatment options, with similar survival rates.<ref name="pmid16186436">{{cite journal |author=White HD, Assmann SF, Sanborn TA, ''et al'' |title=Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial |journal=Circulation |volume=112 |issue=13 |pages=1992–2001 |year=2005 |month=September |pmid=16186436 |doi=10.1161/CIRCULATIONAHA.105.540948 |url=}}</ref><ref name="pmid16757723">{{cite journal |author=Hochman JS, Sleeper LA, Webb JG, ''et al'' |title=Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction |journal=JAMA |volume=295 |issue=21 |pages=2511–5 |year=2006 |month=June |pmid=16757723 |pmc=1782030 |doi=10.1001/jama.295.21.2511 |url=}}</ref>
Emergency coronary artery bypass graft surgery (CABG) is usually undertaken to simultaneously treat a mechanical complication, such as a ruptured papillary muscle, or a ventricular septal defect, with ensueing cardiogenic shock.<ref name=Sabiston>{{cite book | last =Townsend | first =Courtney M. | coauthors =Beauchamp D.R., Evers M.B., Mattox K.L. | title =Sabiston Textbook of Surgery - The Biological Basis of Modern Surgical Practice | publisher =Elsevier Saunders | date =2004 | location =Philadelphia, Pennsylvania | pages =1871 | url =http://www.elsevier.com/wps/find/bookdescription.cws_home/701163/description#description | id =ISBN 0-7216-0409-9}}</ref> In uncomplicated MI, the [[mortality rate]] can be high when the surgery is performed immediately following the infarction.<ref name="pmid7733715">{{cite journal |author=Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR |title=Coronary artery bypass grafting within 30 days of an acute myocardial infarction |journal=Ann. Thorac. Surg. |volume=59 |issue=5 |pages=1169–76 |year=1995 |month=May |pmid=7733715 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/0003497595001255}}</ref> If this option is entertained, the patient should be stabilized prior to surgery, with supportive interventions such as the use of an [[intra-aortic balloon pump]].<ref name="pmid7598589">{{cite journal |author=Creswell LL, Moulton MJ, Cox JL, Rosenbloom M |title=Revascularization after acute myocardial infarction |journal=Ann. Thorac. Surg. |volume=60 |issue=1 |pages=19–26 |year=1995 |month=July |pmid=7598589 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/000349759500351K}}</ref> In patients developing cardiogenic shock after a myocardial infarction, both PCI and CABG are satisfactory treatment options, with similar survival rates.<ref name="pmid16186436">{{cite journal |author=White HD, Assmann SF, Sanborn TA, ''et al'' |title=Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial |journal=Circulation |volume=112 |issue=13 |pages=1992–2001 |year=2005 |month=September |pmid=16186436 |doi=10.1161/CIRCULATIONAHA.105.540948 |url=}}</ref><ref name="pmid16757723">{{cite journal |author=Hochman JS, Sleeper LA, Webb JG, ''et al'' |title=Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction |journal=JAMA |volume=295 |issue=21 |pages=2511–5 |year=2006 |month=June |pmid=16757723 |pmc=1782030 |doi=10.1001/jama.295.21.2511 |url=}}</ref>
Line 56: Line 34:
2. Emergency [[CABG]] should not be performed in patients with successful epicardial reperfusion but unsuccessful microvascular reperfusion. ''(Level of Evidence: C)''}}
2. Emergency [[CABG]] should not be performed in patients with successful epicardial reperfusion but unsuccessful microvascular reperfusion. ''(Level of Evidence: C)''}}


==See also==
==Related Chapters==
* [[acute coronary syndrome]]
* [[Acute coronary syndrome]]
* [[angina pectoris|angina]]
* [[angina pectoris|Angina]]
* [[Cardiac arrest]]
* [[Cardiac arrest]]
* [[coronary thrombosis]]
* [[Coronary thrombosis]]
* [[Hibernating myocardium]]
* [[Hibernating myocardium]]
* [[Stunned myocardium]]
* [[Stunned myocardium]]

Revision as of 16:29, 31 May 2012

Acute Coronary Syndrome Main Page

ST Elevation Myocardial Infarction Microchapters

Home

Patient Information

Overview

Pathophysiology

Pathophysiology of Vessel Occlusion
Pathophysiology of Reperfusion
Gross Pathology
Histopathology

Causes

Differentiating ST elevation myocardial infarction from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History and Complications

Risk Stratification and Prognosis

Pregnancy

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Cardiac MRI

Echocardiography

Coronary Angiography

Treatment

Pre-Hospital Care

Initial Care

Oxygen
Nitrates
Analgesics
Aspirin
Beta Blockers
Antithrombins
The coronary care unit
The step down unit
STEMI and Out-of-Hospital Cardiac Arrest
Pharmacologic Reperfusion
Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI)
Fibrinolysis
Reperfusion at a Non–PCI-Capable Hospital:Recommendations
Mechanical Reperfusion
The importance of reducing Door-to-Balloon times
Primary PCI
Adjunctive and Rescue PCI
Rescue PCI
Facilitated PCI
Adjunctive PCI
CABG
Management of Patients Who Were Not Reperfused
Assessing Success of Reperfusion
Antithrombin Therapy
Antithrombin therapy
Unfractionated heparin
Low Molecular Weight Heparinoid Therapy
Direct Thrombin Inhibitor Therapy
Factor Xa Inhibition
DVT prophylaxis
Long term anticoagulation
Antiplatelet Agents
Aspirin
Thienopyridine Therapy
Glycoprotein IIbIIIa Inhibition
Other Initial Therapy
Inhibition of the Renin-Angiotensin-Aldosterone System
Magnesium Therapy
Glucose Control
Calcium Channel Blocker Therapy
Lipid Management

Pre-Discharge Care

Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT

Post Hospitalization Plan of Care

Long-Term Medical Therapy and Secondary Prevention

Overview
Inhibition of the Renin-Angiotensin-Aldosterone System
Cardiac Rehabilitation
Pacemaker Implantation
Long Term Anticoagulation
Implantable Cardioverter Defibrillator
ICD implantation within 40 days of myocardial infarction
ICD within 90 days of revascularization

Case Studies

Case #1

Case #2

Case #3

Case #4

Case #5

ST elevation myocardial infarction coronary artery bypass grafting On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on ST elevation myocardial infarction coronary artery bypass grafting

CDC on ST elevation myocardial infarction coronary artery bypass grafting

ST elevation myocardial infarction coronary artery bypass grafting in the news

Blogs on ST elevation myocardial infarction coronary artery bypass grafting

Directions to Hospitals Treating ST elevation myocardial infarction

Risk calculators and risk factors for ST elevation myocardial infarction coronary artery bypass grafting

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Coronary artery bypass surgery during mobilization (freeing) of the right coronary artery from its surrounding tissue, adipose tissue (yellow). The tube visible at the bottom is the aortic cannula (returns blood from the HLM). The tube above it (obscured by the surgeon on the right) is the venous cannula (receives blood from the body). The patient's heart is stopped and the aorta is cross-clamped. The patient's head (not seen) is at the bottom.

Despite the guidelines, emergency bypass surgery for the treatment of an acute myocardial infarction (MI) is less common then PCI or medical management. In an analysis of patients in the U.S. National Registry of Myocardial Infarction (NRMI) from January 1995 to May 2004, the percentage of patients with cardiogenic shock treated with primary PCI rose from 27.4% to 54.4%, while the increase in CABG treatment was only from 2.1% to 3.2%.[1]

Emergency coronary artery bypass graft surgery (CABG) is usually undertaken to simultaneously treat a mechanical complication, such as a ruptured papillary muscle, or a ventricular septal defect, with ensueing cardiogenic shock.[2] In uncomplicated MI, the mortality rate can be high when the surgery is performed immediately following the infarction.[3] If this option is entertained, the patient should be stabilized prior to surgery, with supportive interventions such as the use of an intra-aortic balloon pump.[4] In patients developing cardiogenic shock after a myocardial infarction, both PCI and CABG are satisfactory treatment options, with similar survival rates.[5][6]

Coronary artery bypass surgery involves an artery or vein from the patient being implanted to bypass narrowings or occlusions on the coronary arteries. Several arteries and veins can be used, however internal mammary artery grafts have demonstrated significantly better long-term patency rates than great saphenous vein grafts.[7] In patients with two or more coronary arteries affected, bypass surgery is associated with higher long-term survival rates compared to percutaneous interventions.[8] In patients with single vessel disease, surgery is comparably safe and effective, and may be a treatment option in selected cases.[9] Bypass surgery has higher costs initially, but becomes cost-effective in the long term.[10] A surgical bypass graft is more invasive initially but bears less risk of recurrent procedures (but these may be again minimally invasive).

ACC / AHA Guidelines (DO NOT EDIT)[11]

Class I

1. Emergency or urgent CABG in patients with STEMI should be undertaken in the following circumstances:

a. Failed PCI with persistent pain or hemodynamic instability in patients with coronary anatomy suitable for surgery. (Level of Evidence: B)
b. Persistent or recurrent ischemia refractory to medical therapy in patients who have coronary anatomy suitable for surgery, have a significant area of myocardium at risk, and are not candidates for PCI or fibrinolytic therapy. (Level of Evidence: B)
c. At the time of surgical repair of post infarction ventricular septal rupture (VSR) or mitral valve insufficiency. (Level of Evidence: B)
d. Cardiogenic shock in patients less than 75 years old with ST elevation or LBBB or posterior MI who develop shock within 36 hours of STEMI, have severe multivessel or left main disease, and are suitable for revascularization that can be performed within 18 hours of shock, unless further support is futile because of the patient’s wishes or contraindications/unsuitability for further invasive care. (Level of Evidence: A)
e. Life-threatening ventricular arrhythmias in the presence of greater than or equal to 50% left main stenosis and/or triple-vessel disease. (Level of Evidence: B)

Class IIa

1. Emergency CABG can be useful as the primary reperfusion strategy in patients who have suitable anatomy and who are not candidates for fibrinolysis or PCI and who are in the early hours (6 to 12 hours) of an evolving STEMI, especially if severe multivessel or left main disease is present. (Level of Evidence: B)

2. Emergency CABG can be effective in selected patients 75 years or older with ST elevation, LBBB, or posterior MI who develop shock within 36 hours of STEMI, have severe triple-vessel or left main disease, and are suitable for revascularization that can be performed within 18 hours of shock. Patients with good prior functional status who are suitable for revascularization and agree to invasive care may be selected for such an invasive strategy. (Level of Evidence: B)

Class III

1. Emergency CABG should not be performed in patients with persistent angina and a small area of risk who are hemodynamically stable. (Level of Evidence: C)

2. Emergency CABG should not be performed in patients with successful epicardial reperfusion but unsuccessful microvascular reperfusion. (Level of Evidence: C)

Related Chapters

Sources

  • The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [12]
  • The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction [11]

References

  1. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS (2005). "Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock". JAMA. 294 (4): 448–54. doi:10.1001/jama.294.4.448. PMID 16046651. Unknown parameter |month= ignored (help)
  2. Townsend, Courtney M. (2004). Sabiston Textbook of Surgery - The Biological Basis of Modern Surgical Practice. Philadelphia, Pennsylvania: Elsevier Saunders. p. 1871. ISBN 0-7216-0409-9. Unknown parameter |coauthors= ignored (help)
  3. Kaul TK, Fields BL, Riggins SL, Dacumos GC, Wyatt DA, Jones CR (1995). "Coronary artery bypass grafting within 30 days of an acute myocardial infarction". Ann. Thorac. Surg. 59 (5): 1169–76. PMID 7733715. Unknown parameter |month= ignored (help)
  4. Creswell LL, Moulton MJ, Cox JL, Rosenbloom M (1995). "Revascularization after acute myocardial infarction". Ann. Thorac. Surg. 60 (1): 19–26. PMID 7598589. Unknown parameter |month= ignored (help)
  5. White HD, Assmann SF, Sanborn TA; et al. (2005). "Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial". Circulation. 112 (13): 1992–2001. doi:10.1161/CIRCULATIONAHA.105.540948. PMID 16186436. Unknown parameter |month= ignored (help)
  6. Hochman JS, Sleeper LA, Webb JG; et al. (2006). "Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction". JAMA. 295 (21): 2511–5. doi:10.1001/jama.295.21.2511. PMC 1782030. PMID 16757723. Unknown parameter |month= ignored (help)
  7. Raja SG, Haider Z, Ahmad M, Zaman H (2004). "Saphenous vein grafts: to use or not to use?". Heart Lung Circ. 13 (4): 403–9. doi:10.1016/j.hlc.2004.04.004. PMID 16352226. Unknown parameter |month= ignored (help)
  8. Hannan EL, Racz MJ, Walford G; et al. (2005). "Long-term outcomes of coronary-artery bypass grafting versus stent implantation". N. Engl. J. Med. 352 (21): 2174–83. doi:10.1056/NEJMoa040316. PMID 15917382. Unknown parameter |month= ignored (help)
  9. Bourassa MG (2000). "Clinical trials of coronary revascularization: coronary angioplasty vs. coronary bypass grafting". Curr. Opin. Cardiol. 15 (4): 281–6. PMID 11139092. Unknown parameter |month= ignored (help)
  10. Hlatky MA, Boothroyd DB, Melsop KA; et al. (2004). "Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease". Circulation. 110 (14): 1960–6. doi:10.1161/01.CIR.0000143379.26342.5C. PMID 15451795. Unknown parameter |month= ignored (help)
  11. 11.0 11.1 Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)
  12. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)". Circulation. 110 (9): e82–292. PMID 15339869. Unknown parameter |month= ignored (help)

External links

Template:WikiDoc Sources